|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7072 | |
| A61P 35/02 |
| (11) | Number of the document | 2318015 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09763535.3 |
| Date of filing the European patent application | 2009-06-10 | |
| (97) | Date of publication of the European application | 2011-05-11 |
| (45) | Date of publication and mention of the grant of the patent | 2013-08-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/046906 |
| Date | 2009-06-10 |
| (87) | Number | WO 2009/152245 |
| Date | 2009-12-17 |
| (30) | Number | Date | Country code |
| 131969 P | 2008-06-13 | US | |
| 99270 P | 2008-09-23 | US | |
| 172853 P | 2009-04-27 | US |
| (72) |
MAGNANI, John, L., US
PATTON, John, T., Jr., US
SMITH, Theodore, A.G., US
|
| (73) |
GlycoMimetics, Inc.,
401 Professional Drive Suite 250, Gaithersburg, MD 20879,
US
|
| (54) | TREATMENT OF CANCERS OF THE BLOOD USING SELECTED GLYCOMIMETIC COMPOUNDS |
| TREATMENT OF CANCERS OF THE BLOOD USING SELECTED GLYCOMIMETIC COMPOUNDS |